Accurately quantifying motor characteristics in Parkinson disease (PD) is crucial for monitoring disease progression and optimizing treatment strategies. The finger-tapping test is a standard motor assessment. Clinicians visually evaluate a patient's tapping performance and assign an overall severity score based on tapping amplitude, speed, and irregularity. However, this subjective evaluation is prone to inter- and intra-rater variability, and does not offer insights into individual motor characteristics captured during this test. This paper introduces a granular computer vision-based method for quantifying PD motor characteristics from video recordings. Four sets of clinically relevant features are proposed to characterize hypokinesia, bradykinesia, sequence effect, and hesitation-halts. We evaluate our approach on video recordings and clinical evaluations of 74 PD patients from the Personalized Parkinson Project. Principal component analysis with varimax rotation shows that the video-based features corresponded to the four deficits. Additionally, video-based analysis has allowed us to identify further granular distinctions within sequence effect and hesitation-halts deficits. In the following, we have used these features to train machine learning classifiers to estimate the Movement Disorder Society Unified Parkinson Disease Rating Scale (MDS-UPDRS) finger-tapping score. Compared to state-of-the-art approaches, our method achieves a higher accuracy in MDS-UPDRS score prediction, while still providing an interpretable quantification of individual finger-tapping motor characteristics. In summary, the proposed framework provides a practical solution for the objective assessment of PD motor characteristics, that can potentially be applied in both clinical and remote settings. Future work is needed to assess its responsiveness to symptomatic treatment and disease progression.

Parkinson's disease (PD) is a common neurodegenerative disorder with a poorly understood physiopathology and no established biomarkers for the diagnosis of early stages and for prediction of disease progression. Several neuroimaging biomarkers have been studied recently, but these are susceptible to several sources of variability. In this context, an evaluation of the robustness of such biomarkers is essential. This study is part of a larger project investigating the replicability of potential neuroimaging biomarkers of PD. Here, we attempt to reproduce (same data, same method) and replicate (different data or method) the models described in Nguyen et al., 2021 to predict individual's PD current state and progression using demographic, clinical and neuroimaging features (fALFF and ReHo extracted from resting-state fMRI). We use the Parkinson's Progression Markers Initiative dataset (PPMI, ppmi-info.org), as in Nguyen et al.,2021 and aim to reproduce the original cohort, imaging features and machine learning models as closely as possible using the information available in the paper and the code. We also investigated methodological variations in cohort selection, feature extraction pipelines and sets of input features. The success of the reproduction was assessed using different criteria. Notably, we obtained significantly better than chance performance using the analysis pipeline closest to that in the original study (R2 > 0), which is consistent with its findings. The challenges encountered while reproducing and replicating the original work are likely explained by the complexity of neuroimaging studies, in particular in clinical settings. We provide recommendations to further facilitate the reproducibility of such studies in the future.